Clinical Chemistry, Biochemistry of Lipids and Lab Instrumentation
Atherosclerosis is a chronic disease in which modified lipid derivatives and cell infiltrations are mediated through a complex inflammatory process leading to plaque and tissue build up within the coronary arteries. This is the underlying cause of the majority of clinical cardiovascular events, which is the leading cause of death in the USA and around the world. The Mahdi Garelnabi Research Group focuses on the understanding of the role of lipids and its metabolites on atherosclerosis and lipoproteins metabolism. The group is also interested in obesity studies and the involvement of adipose biomarkers on atherosclerosis and other related chronic disorder. In addition the group is interested in studies on the role of indoor air pollution. The group research lab performs basic research experiments using cell culture, animal models and clinical studies. These studies involve dietary, antioxidants and therapeutic supplements targeting specific pathways of inflammation and oxidative stress. Garelnabi is also interested in new clinical laboratory method development and validation.
Mahdi Garelnabi Website
Postdoctoral fellowship in Cardiovascular Diseases 2001-2004, and Postdoctoral fellowship in Lipoprotein Pathophysiology research 2004-2006 Emory University School of Medicine, GA, USA; Ph.D., Clinical Biochemistry, MA Medical College, University of Delhi, 2001; M.Sc., Clinical Biochemistry, Grant Medical College & J. J. Hospitals, University of Bombay, 1994; B.Sc., Biology, Faculty of Education, University of Khartoum, 1987